Striant is a prescribed drug used to treat men with low testosterone. Striant is a tablet that users place on their gums twice a day where the testosterone enters the bloodstream. The delivery system, known as the testosterone buccal system, was approved by the FDA in June 2003. The drug is marketed by Auxilium Pharmaceuticals in the United States.
Recent studies have indicated that testosterone replacement therapy may be linked with a greater risk of heart attacks, strokes, and death. For an overview on the studies indicating dangers with testosterone therapy, please see our testosterone lawsuits infographic. If you or someone you love experienced health problems while using Striant, please contact our team of testosterone product attorneys to receive a free case evaluation.
The drug makers, marketers, and manufacturers have spent hundreds of millions of dollars advertising low-T drugs and making them popular among American men. AndroGel, the market-leading testosterone product, sold more than Viagra in 2013. But, the drug makers have not warned consumers that these products may be linked with a greater risk of heart attack, stroke, and death. Drug makers have an ethical duty to provide consumers with adequate warnings about the risks associated with their products. Striant’s packaging and advertising does not signal to users that the use of Striant may be associated with a greater risk of cardiovascular problems.
The attorneys with The Cochran Firm, D.C. are actively investigating injury claims related to Striant testosterone tablets. Because time limits apply to filing legal claims, we recommend contacting our team of legal professionals as soon as possible. All initial inquiries are free, confidential, and carry no obligation.
